30 likes | 184 Vues
This document details a systematic approach to managing and understanding AAV dosage, with a focus on specific time points: Day 3, Day 7, Day 14, Day 21, and Day 35. Each control point is critical for evaluating the effectiveness and response to the treatment. The guide provides insights into best practices, monitoring strategies, and considerations for ensuring optimal outcomes at each stage. Useful for healthcare professionals involved in gene therapy and clinical research.
E N D
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 Controls 19 21 23 25 29 19 21 23 25 29 19 21 23 25 29 19 21 23 25 29 19 21 23 25 29 1x1011 AAV(aluc) 1x1012 Day 3 Day 7 Day 14 Day 21 Day 35